Silexion Therapeutics Corp
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
Explanatory Note
Reverse Share Splits
During the second quarter of 2026— on May 28, 2026— we effected a reverse share split of our authorized ordinary shares (both issued and outstanding, and unissued) at a ratio of 1-for-10, with a market effective date of May 29, 2026. Previously, during the third quarter of 2025— on July 28, 2025— we had effected a reverse share split of our authorized ordinary shares (both issued and outstanding, and unissued) at a ratio of 1-for-15, with a market effective date of July 29, 2025. Unless specifically indicated otherwise in this quarterly report, all quantities of shares, share equivalents (such as warrants and options to purchase ordinary shares, and restricted share units (RSUs) that may be settled for ordinary shares), and prices per share (trading prices, purchase prices, and exercise prices) have been adjusted (when related to a date or time period prior to the relevant reverse share split(s), on a retroactive basis) to reflect a reduced number of shares or share equivalents, and an increase in the price per share, which have resulted from those reverse share splits.
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2026
INTERIM FINANCIAL STATEMENTS
JUNE 30, 2026
(Unaudited)
TABLE OF CONTENTS
| Page | |
| CONSOLIDATED FINANCIAL STATEMENTS: | |
|---|---|
| Condensed Consolidated Balance Sheets (unaudited) | F-3 - F-4 |
| Condensed Consolidated Statements of Operations (unaudited) | F-5 |
| Condensed Consolidated Statements of Changes in Shareholders’ Equity (unaudited) | F-6 - F-7 |
| Condensed Consolidated Statements of Cash Flows (unaudited) | F-8 - F-9 |
| Notes to Condensed Consolidated Financial Statements (unaudited) | F-10 - F-23 |
F - 2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.